ACAD9 Antikörper (AA 1-270) (Biotin)

Produktnummer ABIN7143193

Dieses Anti-ACAD9-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von ACAD9 in ELISA. Geeignet für Human.

Kurzübersicht für ACAD9 Antikörper (AA 1-270) (Biotin) (ABIN7143193)

Target: ACAD9 (Acyl-CoA Dehydrogenase Family, Member 9 (ACAD9))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ACAD9 Antikörper ist konjugiert mit Biotin

Applikation: ELISA

Produktdetails anti-ACAD9 Antikörper (Biotin)

Bindungsspezifität: AA 1-270

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Acyl-CoA dehydrogenase family member 9, mitochondrial protein (1-270AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu ACAD9

Target: ACAD9 (Acyl-CoA Dehydrogenase Family, Member 9 (ACAD9))

Andere Bezeichnung: ACAD9

Hintergrund:

Background: Required for mitochondrial complex I assembly (PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity on palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0). It is three times more active on palmitoyl-CoA than on stearoyl-CoA. However, it does not play a primary role in long-chain fatty acid oxidation in vivo (PubMed:20816094, PubMed:24158852). Has little activity on octanoyl-CoA (C8:0), butyryl-CoA (C4:0) or isovaleryl-CoA (5:0).

Aliases: ACAD9Complex I assembly factor ACAD9 antibody, mitochondrial antibody, Acyl-CoA dehydrogenase family member 9 antibody, ACAD-9 antibody, EC 1.3.8.- antibody

UniProt: Q9H845

Pathways: SARS-CoV-2 Protein Interaktom